Discovery could help prevent cancer drug resistance before it starts
Researchers at UC Davis have discovered that cancer cells develop resistance to BET inhibitors by increasing production of the BRD2 protein. The study suggests that combination therapies targeting both BRD2 and BRD4 could prevent drug resistance.
Why it matters
This finding offers a potential pathway to improve the efficacy of cancer treatments and patient survival rates.
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
The article is a straightforward report on scientific research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in